EUVIMEDEUVIMED entdecken
Crossref

Temsirolimus: Safety and Efficacy in the Treatment of Renal Cell Carcinoma

M. Hammad Ather and Syed M. Nazim

Clinical Medicine Reviews in Oncology · 2011

DOI: 10.4137/cmro.s1632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2011. Verfasst von M. Hammad Ather and Syed M. Nazim.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nazim, M. H. A. A. S. M. (2011). Temsirolimus: Safety and Efficacy in the Treatment of Renal Cell Carcinoma. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s1632

Vancouver

Nazim MHAASM. Temsirolimus: Safety and Efficacy in the Treatment of Renal Cell Carcinoma. Clinical Medicine Reviews in Oncology. 2011. doi:10.4137/cmro.s1632

BibTeX
@article{Nazim2011,
  author = {Nazim, M. Hammad Ather and Syed M.},
  title = {Temsirolimus: Safety and Efficacy in the Treatment of Renal Cell Carcinoma},
  journal = {Clinical Medicine Reviews in Oncology},
  year = {2011},
  doi = {10.4137/cmro.s1632}
}
Kostenlos starten →